Abstract
Objective Locomotion is an automated voluntary movement sustained by coordinated neural synchronization across a distributed brain network. The cerebral cortex is central for adapting the locomotion pattern to the environment and alterations of cortical network dynamics can lead to gait impairments. Gait problems are a common symptom with a still unclear pathophysiology and represent an unmet therapeutical need in Parkinson’s disease. Little is known about the cortical network dynamics of locomotor control in these patients.
Methods We studied the cortical basis of parkinsonian gait by combining metabolic brain imaging with high-density EEG recordings and kinematic measurements performed at rest and during unperturbed overground walking.
Results We found significant changes in functional connectivity between frontal, sensorimotor and visuomotor cortical areas during walking as compared to resting. Specifically, hypokinetic gait was associated with poor information flow from the supplementary motor area (SMA) to precuneus and from calcarine to lingual gyrus as well as high information flow from calcarine to cuneus.
Interpretation Our findings support a role for visuomotor integration processes in PD-related hypokinetic gait and suggest that reinforcing visual information may act as a compensatory strategy to allow SMA-related feedforward locomotor control in PD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was sponsored by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project-ID 424778381-TRR 295, by the European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS and by the Fondazione Grigioni per il Morbo di Parkinson. SH and FP were supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Grant agreement No. 758985). IUI was supported by the New York University School of Medicine and The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, which was made possible with support from Marlene and Paolo Fresco. CP was supported by a grant from the Fondazione Europea di Ricerca Biomedica (FERB Onlus).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the University of Wuerzburg gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
An error in the information about the authors has been corrected.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
